|[April 11, 2014]
The Fondation Ipsen celebrates its 30th anniversary with a prestigious conference on the perspectives of cancer research "Biology viewed through the prism of cancer"
PARIS --(Business Wire)--
The Fondation Ipsen is celebrating its 30th anniversary.
During these three decades, it has gone hand in hand with the evolution
of biomedical research at the highest level, organizing the first
scientific conferences on many current and emerging areas of biology and
medicine, including those related to Alzheimer's disease, gene therapy
and stem cells in the brain, as well as the idea of protective genes
against diseases. The foundation has also been behind completely new
approaches, such as neurophilosophy, the extension of the prion concept
in all neurodegenerative diseases, and even the neurobiological approach
to human values.
To celebrate its 20th anniversary, the Fondation Ipsen hosted
a grand event entitled "From brain to mind", which offered an overview
of the dramatic advances made in neuroscience.
For its 30th anniversary, the Fondation Ipsen has decided to
organize a conference on cancer science, as seen from the point of view
of advances in fundamental biology. This scientific meeting is an
opportunity to review current knowledge in the field of cancer research
but also, more generally, to explore some of the most fascinating
aspects of biological science. Indeed, during the last few decades
fundamental research in the field of cancer has achieved considerable
advances which have "fertilized" biology as a whole. In practice, cancer
research merges with the very heart of research in cellular and
molcular biology, as indicated by discoveries related to telomeres,
stem cells, epigenesis, and gene therapy.
Marc de Garidel, Chairman and Chief Executive Officer of Ipsen, stated:
"I'm delighted that the Fondation Ipsen, because of
its strong reputation and expertise in the science of oncology, is able
to gather together the world's best researchers to discuss the need for
further advancement in the treatment of this deadly disease."
Yves Christen, Chairman of the Fondation Ipsen, added: "Up
to now the treatment of cancer has not fully benefited from the results
of the latest scientific and medical advances. After unquestionable
progress, it has come up against a fundamental limit due to the fact
that cancer is not a disease from the outside (like infections) but a
pathology related to the functioning of living organisms. For this
reason conventional treatments (surgery, radiation, antimitotics) do not
really target specific mechanisms, and exert significant adverse
However, over the past few years, new approaches have emerged, targeting
specific mechanisms such as the effect on protein-phosphorylating
enzymes (protein kinases). These often concern specific forms and
therefore a limited number of patients are affected, but they represent
future approaches. In this same vein, and after so many years of trial
and error, today immunotherapy has proven effective under specific
conditions. All these advances have altered the medical view of cancer.
It is no longer a matter of an acute disease, a merciless killer, but a
chronic disease - just like those affecting the cardiovascular system -
with which we can envisage living for many years to come.
The Fondation Ipsen
Founded in 1983 under the aegis of the Fondation de France, the
Fondation Ipsen is dedicated to contributing to the development and
dissemination of scientific knowledge. During this time, the Fondation
Ipsen aims to promote the interaction between researchers and
clinicians, essential exchanges because of the extreme specialization of
these professions. The Fondation Ipsen's goal is to incite contemplation
of the great scientific challenges for years to come. The Fondation has
developed a significant international network of scientific experts, who
meet regularly at Medicine and Research Conferences, dedicated to five
main themes: Alzheimer's disease, neuroscience, longevity, endocrinology
and cancer. Furthermore, since 2007 the Fondation Ipsen has introduced
several series of meetings in partnership with the Salk
Institute, the Karolinska Institutet, Massachusetts General
Hospital, the DMMGF Foundation, as well as with the journals Nature,
Cell and Science. The Fondation Ipsen has published over one hundred
books and has awarded more than 250 prizes and grants.
[ Back To Technology News's Homepage ]